The market for infection-control system software is small and is dominated by applications developed specifically for this narrow market niche, but it won't stay that way much longer, according to a report from KLAS Enterprises.
The Orem, Utah-based healthcare information technology market researcher said its survey results are based on interviews with 119 providers using paper-based infection control reporting systems and 202 using computerized systems.
Read the full story: http://tinyurl.com/9odospe
Source: ModernHealthcare.com
Among all respondents, 70% said system cost was a barrier to acquisition and 74% indicated that cost was their top system selection criterion. Other most-wanted features were the ability of the infection control software to interface with the provider's own other health IT systems and capabilities to report to the federally mandated National Healthcare Safety Network, according to the report.
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More